Different behavioral effects of maprotiline and fluxilan in rats

Archives of Biological Sciences

Volumn 60, Issue 1, 2008, Pages 33-39

  Spasojević, Nataša ^a   Gavrilović, Ljubica ^a   Dronjak, Sladjana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antidepressants; Behavior; Monoamine reuptake inhibitors; Rats

Indexed keywords

EID: 53549090423     PISSN: 03544664     EISSN: None     Source Type: Journal    
DOI: 10.2298/ABS0801033S     Document Type: Article

References (27)

1. Borsini, F. (1995). Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev 19, 377-395.
2. Cervo, L., Grignaschi, G., and R. Samanin (1991). Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur. J. Pharmacol. 196, 217-222.
3. Connor, T. J., Kelliher, Y. S., Harkin, A., Kelly, J. P., and B. E. Leonard (2000). Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced swim test. Pharmacol. Biochem. Behav. 65, 591-597.
4. Cryan, J. F., Page, M. E., and I. Lucki (2002). Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur. J. Pharmacol. 436, 197-205.
5. Cryan, J. F., Page, M. E., and I. Lucki (2005). Differential behavioral effects on the antidepressants reboxetine, fluoxetine, and mocolobemide in a modified forced swim test following chronic treatment. Psychopharmacol. 182, 335-344.
6. Detke, M. J., Rickels, M., and I. Lucki (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacol. 121, 66-72.
7. Dubovsky, S. L. (1994). Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents. J. Clin. Psychiat. 55, 34-44.
8. Espejo, E. F., and F. J. Minano (1999). Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test. Neurosci. 88, 609-615.
9. Grippo, A. J., Moffitt, J. A., and A. K. Johnson (2002). Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, 1333-1341.
10. Handley, S. L., and J. W. Mc Blane (1993). 5-HT drugs in animal models of anxiety. Psychopharmacol. 112, 13-20.
11. Hog, S. (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54, 21-30.
12. Izumi, J., Washizuka, M., Hayashi-Kuwabara, Y., Yoshinaga, K., Tanaka, Y., Ikeda, Y., Kiuchi, Y., and K. Oguchi (1996). An attenuated alpha-1 potentiation of beta adrenoceptor-stimulated cyclic AMP formation after repeated saline injections in Fischer 344 strain rats. Life Sci. 59, 33-42.
13. Kelly, J. P., and B. E. Leonard (1994). The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacol. 33, 1011-1016.
14. Kurt, M., Arik, A. C., and S. Celik (2000). The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice. J. Basic Clin. Physiol. Pharmacol. 11, 173-180.
15. Montgomery, S. A. (1995). Selective serotonin reuptake inhibitors in the acute treatment of depression, In:. Psychopharmacology: The Fourth Generation of Progress (Eds. F. E. Bloom and D. J. Kupfer), 15-19. Raven Press, New York.
16. Montgomery, S. A. (1997). Is there a role for a pure noradrenergic drug in the treatment of depression?. Eur. Neuropsychopharmacol. 7, 3-9.
17. Nowakowska, E., Kus, K., Chodera, A., and J. Rybakowski (2000). Behavioural effects of fluoxetine and tiapentine, two antidepressants with opposite action mechanisms, in rats. Arzneimittelforschung 50, 5-10.
18. Page, M. E., Detke, M. J., Dalvi, A., Kirby, L. G., and I. Lucki (1999). Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacol. 147, 162-167.
19. Porsolt, R. D., Anton, G., Blavet, N., and M. Jalfre (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47, 379-391.
20. Reneric, J.P., and I. Lucki (1998). Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacol. 136, 190-197.
21. Rodgers, R.J., and J. C. Cole (1994). The elevated plus-maze: Pharmacology, methodology and ethology, In: Ethology and Psychopharmacology (Eds. S. J. Cooper and C. A. Hendrie), 9-14. Wiley, Chichester.
22. Rodgers, R. J., Cutler, M. G., and J. E. Jackson (1997). Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine. II. The elevated plus-maze. Pharmacol. Biochem. Behav. 57, 127-136.
23. Shishkina, G. T., Iudina, A. M., and N. N. Dygalo (2006). Effects of fluoxetine on locomotor activity: possible involvement of dopamine. Zh. Vyssh. Nerv. Delat. 56, 523-528.
24. Silva, M. T., Alves, C.R., and E. M. Santarem (1999). Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze. Br. J. Med. Biol. Res. 32, 333-339.
25. Spasojevic, N., Gavrilovic, Lj., and S. Dronjak (2007). Effects of chronic diazepam treatments on behavior on individually housed rats. Arch. Biol. Sci. (Belgrade) 59, 113-117.
26. Weiss, M., Cierpial, M. A., and C. H. West (1998). Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression. Pharmacol. Biochem. Behav. 61, 49-66.
27. Qi, X., Lin, W., Li, J., Pan, Y., and W. Wang (2006). The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav. Brain Res. 175, 233-240.